7Baggers
 Can Cardiff Oncology Inc. (XE7C) stock sustain breakout momentum  newser.com Sun, 16 Nov 2025 10:28:51 GMT
 cardiff oncology shares: clinical promise meets market skepticism  AD HOC NEWS Thu, 13 Nov 2025 06:45:04 GMT
 Cardiff Oncology at Stifel 2025: Promising Drug Trials Highlighted  Investing.com India Wed, 12 Nov 2025 16:46:06 GMT
 cardiff oncology: q3 earnings snapshot  theheraldreview.com Fri, 07 Nov 2025 08:36:01 GMT
 cardiff oncology earnings beat by $0.04, revenue fell short of estimates  Investing.com South Africa Fri, 07 Nov 2025 08:00:00 GMT
 td cowen maintains cardiff oncology(crdf.us) with buy rating  富途牛牛 Fri, 07 Nov 2025 07:32:00 GMT
 cardiff oncology reports increased losses amid ongoing trials  TipRanks Fri, 07 Nov 2025 05:30:35 GMT
 william blair maintains cardiff oncology(crdf.us) with buy rating  富途牛牛 Fri, 07 Nov 2025 02:32:00 GMT
 crdf updates 2025 financial projections and operating expense fo  GuruFocus Thu, 06 Nov 2025 23:48:28 GMT
 Cardiff Oncology (CRDF) Reports Q3 Revenue and Trial Progress  GuruFocus Thu, 06 Nov 2025 23:48:24 GMT
 Cardiff Oncology reports Q3 EPS (17c), consensus (21c)  TipRanks Thu, 06 Nov 2025 23:27:14 GMT
 Cardiff Oncology posts smaller-than-expected Q3 loss  TradingView Thu, 06 Nov 2025 22:10:56 GMT
 Cardiff Oncology Inc (CRDF) Q3 2025 Earnings: EPS of -$0.17 Beat  GuruFocus Thu, 06 Nov 2025 22:02:10 GMT
 Cardiff Oncology Reports Increased Losses Amid Ongoing Trials  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Cardiff Oncology: Q3 Earnings Snapshot  New Haven Register Thu, 06 Nov 2025 08:00:00 GMT
 cardiff oncology to participate in two upcoming investor conferences  The Manila Times Tue, 04 Nov 2025 21:23:34 GMT

Cardiff Oncology, Inc
(NASDAQ:CRDF) 

CRDF stock logo

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Its lead drug candidate is onvansertib, a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor that is in Phase Ib/II clinical trial in acute myeloid leukemia (AML); has c...

Founded: 1999
Full Time Employees: 12
CEO: Mark Erlander  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends